BRAHMS KRYPTOR sFlt-1

Device Brahms GmbH
Total Payments
$623,871
Transactions
6
Doctors
0
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2021 $190,000 1 0
2020 $8,871 1 0
2019 $425,000 4 0

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $623,871 6 100.0%

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
Identification and validation of a cut-off for the ratio of suluble Fms-like Tyrosine Kinase-1 to Placental Growth Factor (sFlt-1/PlGF) to Stratify Risk in Pregnant Women with Hypertensive Disorders of Pregnancy - PRAECIS Brahms GmbH $425,000 0
First Trimester Risk Assessment For Preeclampsia Study FITRAPS Brahms GmbH $190,000 0
Identification and Validation of a Cut-off for the Ratio of Soluble Fms-like Tyrosine Kinase-1 to Placental Growth Factor (sFlt-1/PlGF) to Stratify Risk in Pregnant Women with Hypertensive Disorders of Pregnangy - PRAECIS Brahms GmbH $8,871 0

Top Doctors Receiving Payments for BRAHMS KRYPTOR sFlt-1

Doctor Specialty Location Total Records
Unknown Los Angeles, CA $623,871 6

About BRAHMS KRYPTOR sFlt-1

BRAHMS KRYPTOR sFlt-1 is a device associated with $623,871 in payments to 0 healthcare providers, recorded across 6 transactions in the CMS Open Payments database. The primary manufacturer is Brahms GmbH.

Payment data is available from 2019 to 2021. In 2021, $190,000 was paid across 1 transactions to 0 doctors.

The most common payment nature for BRAHMS KRYPTOR sFlt-1 is "Unspecified" ($623,871, 100.0% of total).

BRAHMS KRYPTOR sFlt-1 is associated with 3 research studies, including "Identification and validation of a cut-off for the ratio of suluble Fms-like Tyrosine Kinase-1 to Placental Growth Factor (sFlt-1/PlGF) to Stratify Risk in Pregnant Women with Hypertensive Disorders of Pregnancy - PRAECIS" ($425,000).